首页> 外文OA文献 >Determinants of Risk Factors for Renal Impairment among HIV-Infected Patients Treated with Tenofovir Disoproxil Fumarate-Based Antiretroviral Regimen in Southern Vietnam

【2h】

Determinants of Risk Factors for Renal Impairment among HIV-Infected Patients Treated with Tenofovir Disoproxil Fumarate-Based Antiretroviral Regimen in Southern Vietnam

机译：邻近越南崇高毒性富马酸富马酸盐富马酸盐抗逆转录中方案治疗的艾滋病毒感染患者肾损伤风险因素的决定因素

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Cuong Q Hoang; Hai D Nguyen; Huy Q Vu; Khai T Nguyen; Linh T Hoang; Hong Ly; Thang D Tat; Lan T Phan;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Safety of Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy Regimens in Pregnancy for HIV-Infected Women and Their Infants: A Systematic Review and Meta-Analysis [J] . Jean B. Nachega, Olalekan A. Uthman, Lynne M. Mofenson, JAIDS: Journal of acquired immune deficiency syndromes . 2017,第1期

机译：托福罗基毒性富马酸核苷酸的抗逆转录病毒治疗方案妊娠期艾滋病毒感染妇女及其婴儿的安全性：系统审查和荟萃分析
2. Progressive Decline of the Glomerular Filtration Rate in HIV-infected Children Treated With Tenofovir Disoproxil Fumarate-based Regimens in West and Central Africa [J] . Diack Aminata, Yonaba Caroline, Coulibaly Aba, The Pediatric infectious disease journal . 2020,第8期

机译：西非崇高病毒富马酸富马酸盐富马酸盐型治疗艾滋病毒感染儿童肾小球过滤速率的渐进性下降
3. Administration of tenofovir disoproxil fumarate-based antiretroviral therapy in an HIV-infected patient following unilateral nephrectomy [J] . Biagi Mark, Badowski Melissa, Chiampas Thomas, International journal of STD & AIDS . 2016,第9期

机译：在单侧肾切除术后的HIV感染患者中使用替诺福韦富马酸替索罗非酯抗逆转录病毒疗法
4. The Two First-Line Recommended Antiretroviral Regimens for Naive HIV-Infected Patients: Efavirenz-Based Versus Lopinavir-Ritonavir-Based Haart [C] . R. Manfredi, L. Calza, F. Chiodo International AIDS Conference . 2004

机译：幼稚艾滋病毒感染患者的两种第一线推荐的抗逆转录病毒方案：efavirenz为基于Lopinavir-Ritonavir的HAART
5. Cost effectiveness analysis of abacavir/lamivudine versus tenofovir/emtricitabine combination therapy as part of highly active antiretroviral therapy in treatment naive HIV-infected patients. [D] . Giguere, Pierre. 2010

机译：阿巴卡韦/拉米夫定与替诺福韦/恩曲他滨联合疗法作为高活性抗逆转录病毒疗法治疗未受HIV感染的患者的成本效益分析。
6. Determinants of Risk Factors for Renal Impairment among HIV-Infected Patients Treated with Tenofovir Disoproxil Fumarate-Based Antiretroviral Regimen in Southern Vietnam [O] . Cuong Q Hoang, Hai D Nguyen, Huy Q Vu, 2020

机译：越南南部以替诺福韦富马酸替诺福韦酯抗逆转录病毒疗法治疗的艾滋病毒感染患者肾功能损害的危险因素的决定因素
7. Renal and Bone Outcomes Among HIV-Infected Patients Exposed to EFV/TDF/FTC Compared With Other Tenofovir Disoproxil Fumarate–Containing Antiretroviral Regimens: Findings From the Veterans Health Administration (VHA) [O] . Joanne Lafleur, Adam Bress, Jacob Crook, 2016

机译：与其他替诺夫罗基毒素的富马酸薄菌的抗逆转录病毒方案（VHA）相比，肾病感染患者与其他替诺夫血管抗逆转录病毒方案相比

Determinants of Risk Factors for Renal Impairment among HIV-Infected Patients Treated with Tenofovir Disoproxil Fumarate-Based Antiretroviral Regimen in Southern Vietnam

著录项

引文网络

相似文献

相关主题

期刊订阅